Novartis · 4 weeks ago
Director, Decision Science Portfolio (2 openings)
East Hanover, NJ
Full-time
Hybrid
Director/Executive
$186K/yr - $344K/yr
8+ years expNovartis is dedicated to enabling improved decision making by leveraging data and advanced analytics capabilities. The Director, Decision Science Portfolio will support the leadership team by providing robust responses to portfolio and enterprise-wide requests and elevate the overall IDS innovation and insight-generation capability.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Support the ED, Decision Science Portfolio by providing data-driven insights that address enterprise- or portfolio-level questions and strategic priorities
Synthesize and analyze data from across therapeutic areas, products, and functions to create cohesive narratives for enterprise decisions
Support the ED, Decision Science Portfolio in framing key business questions and driving alignment on priorities, ensuring seamless integration of insights into enterprise strategy
Prepare for meetings with the Decision Science leadership governance body (i.e. collect, synthesize, and socialize material with the LT)
Work closely with Decision Science LT members to align on key topics to ensure effective Decision Science collaboration across brands and functions
Proactively identify opportunities to expand the suite of IDS products to meet evolving needs of US enterprise
Implement best practices in decision science and data analytics to foster proactive, insight-driven decision-making across the US business
Develop new tools, frameworks, and methodologies to improve the delivery and impact of insights at the enterprise level
Qualification
Required
Bachelor's degree in related field is required
A minimum of 8 years of experience in healthcare industry or other business experience
Excellent communication and interpersonal skills to effectively liaise with senior leadership and stakeholders
Ability to identify and capitalize on opportunities for expanding product suites and enhancing organizational capabilities
Strong background in synthesizing and presenting information to senior leadership, fostering an environment of innovation and continuous improvement
Strategic thinking and problem-solving skills to support enterprise-wide initiatives
Strategic planning capability combined with an outstanding ability to drive execution with a focus on directing operational enhancements to increase quality and effectiveness
Proven teamwork, collaboration, and people management skills
Ability to influence a highly matrixed large organization and work in a dynamic, fast-paced, multifunctional environment
Preferred
Master of Science and/or MBA strongly preferred
Minimum 3 years of domain expertise in these areas are highly desired: secondary data analytics, data science, primary market research, field analytics and insights, market access and patient service analytics, or other related strategic analytics and management consulting
Benefits
Health, life and disability benefits
401(k) with company contribution and match
Generous time off package including vacation, personal days, holidays and other leaves
Company
Novartis
Novartis is a pharmaceutical company that researches and develops medicines for serious diseases to improve and extend people's lives.
10001+ employees
H1B Sponsorship
Novartis has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (27)
2023 (23)
2022 (27)
2021 (31)
2020 (25)
Funding
Current Stage
Public CompanyTotal Funding
$2.49BKey Investors
Bill & Melinda Gates Foundation
2024-06-19Post Ipo Debt· $2.49B
2018-02-14Grant· $6.5M
2000-05-19IPO
Leadership Team
Daniel Grant
Vice President & Global Program Head
John von Brachel
VP, Head of Content Lab
Recent News
2026-01-23
2026-01-23
Company data provided by crunchbase